Life Sciences in Action

BioUtah President & CEO Kelvyn Cullimore interviews Vera Nackovic, patent attorney for Mayer Brown, in the second of a two-part series to discuss intellectual property issues faced by life sciences companies.

BioUtah President & CEO Kelvyn Cullimore interviews Vera Nackovic, patent attorney for Mayer Brown, in the first of a two-part series to discuss intellectual property issues faced by life sciences companies. Vera Nackovic Bio A Registered Patent Attorney, Vera Nackovic advises clients on pharmaceutical, biologics, medical devices, nutraceuticals, and chemical patent matters—particularly intellectual property transactions, […]

  BioUtah president & CEO Kelvyn Cullimore interviews Wilson Sonisini attorneys Meredith Krannich and Deno Himonas to discuss issues life sciences companies face when considering the need for legal counsel. Topics discussed include: Wilson Sonsini’s Executive Advisor Program to offer pro bono support and leadership to life sciences companies Development of In-house Counsel Dealing with […]

BioUtah president & CEO Kelvyn Cullimore interviews Renalytix CEO James McCullough to discuss the growth, innovations of Renalytix, a diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Topics discussed include: Kidney diseases prognostics Working with the FDA to achieve regulatory hurdles Alternate means of […]

BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to legal issues life sciences companies face when dealing with the FDA.

BioUtah president & CEO Kelvyn Cullimore interviews RenalytixAI CEO James McCullough to discuss the growth and innovations of RenalytixAI, a diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs.

With a manufacturing facility in China, Utah-based ATL Technology was faced to deal with COVID months before the pandemic hit the United States. In this episode BioUtah’s president & CEO Kelvyn Cullimore interviews Brad Brown, CEO of ATL Technology discusses how their dealings with the pandemic in China helped them prepare for and deal with COVID-19’s impact on a life sciences company.